Podcast Episodes
Back to Search
Hawsons Iron's Tom Revy: Product quality "in the top 1 or 2%" as NPV hits A$1.87bn
Episode 14932
Hawsons Iron Ltd (ASX:HIO) managing director Tom Revy spoke with Proactive's Stephen Gunnion about the Hawsons Iron Project, its strengthened economi…
1 week, 2 days ago
Krakatoa Resources reports more high-grade antimony & gold
Episode 14910
Krakatoa Resources CEO Mark Major talked with Proactive about the latest assay results from the company’s Zopkhito Antimony-Gold Project in Georgia, …
2 weeks, 2 days ago
Duratec order book jumps as FY27 outlook builds
Episode 14908
Duratec Ltd managing director Chris Oates talked with Proactive about the company’s growth outlook, its expanding order book and opportunities across…
2 weeks, 2 days ago
Infragreen CFO on FY26 growth and energy transition
Episode 14909
Infragreen CFO Martin McIvor talked with Proactive about the company’s FY26 performance, investment portfolio, sustainability focus and growth strate…
2 weeks, 2 days ago
Actinogen Medical's XanaMIA Alzheimer’s trial nears November results
Episode 14911
Actinogen Medical CFO Will Souter talked with Proactive about the completion of the final patient visit in the company’s pivotal XanaMIA Phase 2b/3 A…
2 weeks, 2 days ago
ReconAfrica reports Thermogenic Gas at KW1X as horizontal drilling nears
Episode 14907
ReconAfrica CEO Brian Reinsborough joined Steve Darling from Proactive to provide an update on the company’s expanding African energy portfolio, high…
2 weeks, 3 days ago
HANetf’s Harry Halewood explains option income strategies and covered call trade-offs
Episode 14906
HANetf Product Specialist Harry Halewood joined Steve Darling from Proactive to explain how option income strategies, including covered calls, can be…
2 weeks, 3 days ago
BrenX expands Hungary site, advancing first integrated industrial energy center
Episode 14905
BrenX CEO Nir Brenmiller joined Steve Darling from Proactive to announce that the company has entered into a definitive real estate sale and purchase…
2 weeks, 3 days ago
Tiziana Life Sciences doses first ALS patients in Phase 2a Foralumab trial
Episode 14904
Tiziana Life Sciences CEO Ivor Elrifi joined Steve Darling from Proactive to announce an important milestone in the company’s neuroimmunology pipelin…
2 weeks, 3 days ago
MetaOptics expands U.S. investor reach with OTCQX debut under ticker MOTLY
Episode 14899
MetaOptics Technologies CFO Alex Chu joined Steve Darling from Proactive to discuss the company’s latest milestone as it expands its presence in the …
2 weeks, 3 days ago